Insurrection, intellectual rebellion, or learned remonstrance, call it what you will, the San Francisco Declaration on Research Assessment, or DORA, began one year ago this week in a windowless meeting room in the depths of the Moscone Convention Center when a group of scientists, journal editors, and publishers decided they had a common problem that needed addressing—the journal impact factor, or JIF.
Elaine Fuchs grew up surrounded by scientists. Her father and aunt were scientists at Argonne National Laboratories, and later her older sister became a neuroscientist. So Fuchs has followed in the family footsteps. Today she is a Howard Hughes Medical Institute investigator, a professor at the Rockefeller University, and a widely recognized pioneer in adult stem cell research. She is also a former ASCB President. As an ASCB stalwart and a stem cell pathfinder, Fuchs was drafted to serve on the ASCB Stem Cell Task Force last spring and helped write the preliminary report, which was presented for public comment last month.
One is an insider who just came in from the outside, the other, an outsider serving as an advisor at the very highest level. But both are key players in the future of the National Institutes of Health (NIH). Both will be on stage at the ASCB Annual Meeting in New Orleans on Monday, December 16, at 1:30 pm in Room 356.
An experiment: Some warm and starry night, take two senior cell biologists out on a boat. Put wine or beer or something that signals "closed for the day" into one hand and a copy of Craig Venter's latest book, Life At the Speed of Light into the other. (You might have to hold the flashlight.) Ask aloud, "So what do you think of Craig Venter?" Be prepared for a long but interesting night.